Related Experiment Videos
Hyperlipidaemia in renal transplant patients
Insights
Post-transplantation hyperlipidaemia affects 65% of renal allograft recipients, with hypertriglyceridaemia linked to corticosteroids early on. Cholesterol levels remained elevated, influenced by factors like obesity and insulin resistance later.
Area of Science:
- Nephrology
- Endocrinology
- Cardiovascular Medicine
Background:
- Post-transplantation hyperlipidaemia is a common complication following renal allografts.
- Understanding its prevalence and aetiology is crucial for patient management.
Purpose of the Study:
- To investigate the prevalence, characteristics, and potential causes of hyperlipidaemia in renal allograft recipients.
- To differentiate the contributing factors for hypercholesterolaemia and hypertriglyceridaemia.
Main Methods:
- A study involving 94 renal allograft recipients.
- Analysis of lipid profiles, including hypercholesterolaemia and hypertriglyceridaemia.
- Correlation of lipid levels with corticosteroid dosage, obesity, carbohydrate intolerance, and insulin levels.
Main Results:
- 65% of recipients exhibited hypercholesterolaemia or hypertriglyceridaemia.
- Hypertriglyceridaemia was highest in the first year post-transplant, correlating with corticosteroid use.
- Later hypertriglyceridaemia linked to obesity, carbohydrate intolerance, and insulin levels.
- Elevated cholesterol levels were persistent and not clearly related to the studied factors.
Conclusions:
- Post-transplantation hyperlipidaemia is prevalent and multifactorial.
- Corticosteroids play a significant role in early hypertriglyceridaemia.
- Obesity, carbohydrate intolerance, and insulin resistance are key factors in later stages.
Abstract:
The prevalence, nature and possible aetiology of post-transplantation hyperlipidaemia were studied in 94 renal allograft recipients. Sixty-five per cent of the group had hypercholesterolaemia or hypertriglyceridaemia, and types IIb and IV were the commonest forms of hyperlipoproteinaemia encountered. The pathogenesis of post-transplantation hyperlipidaemia is complex. Hypertriglyceridaemia was maximal in the first year after transplantation and could be correlated with high corticosteroid dosage during this period. Thereafter hypertriglyceridaemia was less marked and was related to obesity, corbohydrate intolerance and basal insulin levels. Mean cholesterol levels were elevated throughout the post-transplantation period, varied little and could not be related to corticosteroid dosage, body weight, carbohydrate intolerance, basal insulin levels or renal dysfunction.